| Literature DB >> 35624489 |
Yu-Xian Wang1, Ming Zhong2,3,4, Min-Hui Dong1, Jie-Qiong Song1, Yi-Jun Zheng1, Wei Wu1, Jia-le Tao1, Ling Zhu1, Xin Zheng1.
Abstract
BACKGROUND: The physiological effects of prone ventilation in ARDS patients have been discussed for a long time but have not been fully elucidated. Electrical impedance tomography (EIT) has emerged as a tool for bedside monitoring of pulmonary ventilation and perfusion, allowing the opportunity to obtain data. This study aimed to investigate the effect of prone positioning (PP) on ventilation-perfusion matching by contrast-enhanced EIT in patients with ARDS.Entities:
Keywords: Acute respiratory distress syndrome; Electrical impedance tomography; Mechanical ventilation; Prone positioning; Pulmonary perfusion; Ventilation–perfusion matching
Mesh:
Year: 2022 PMID: 35624489 PMCID: PMC9137443 DOI: 10.1186/s13054-022-04021-0
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 19.334
Fig. 1Effects of prone position on ventilation–perfusion matching in a representative study patient. Left: performed in the supine (T0), Middle: 3 h after PP initiation (T1), Right: at the end of PP (T2). During prone ventilation, pulmonary blood flow is mostly unmodified at the early stage and then gradually changes over time. Long prone ventilation increases dorsal ventilation and perfusion, which results in improved ventilation–perfusion matching
Main characteristics of the patients
| Patient NO | Sex (M/F) | Height (cm) | BMI (kg/m2) | Comorbidities | APACHE II score at ICU admission | PaO2/FiO2 at baseline (mm Hg) | PEEP (cmH2O) | MV duration before enrollment (d) | Duration of prone positioning (h) | ARDS etiology |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 178 | 25 | Hypertension | 33 | 83 | 10 | 1 | 12 | Pneumonia |
| 2 | M | 173 | 26 | None | 11 | 123 | 8 | 3 | 17 | Pneumonia |
| 3 | F | 162 | 35 | Hypertension; immunodeficiency | 9 | 51 | 14 | 1 | 18.5 | Septic shock |
| 4 | M | 165 | 24 | Hypertension; diabetes | 19 | 81 | 11 | 4 | 16 | Postoperative respiratory failure |
| 5 | M | 164 | 23 | Hypertension; atrial fibrillation | 15 | 97 | 8 | 4 | 18.5 | Pneumonia |
| 6 | M | 182 | 21 | None | 2 | 97 | 8 | 5 | 16 | Pneumonia |
| 7 | M | 170 | 21 | None | 7 | 140 | 5 | 2 | 15.5 | Postoperative respiratory failure |
| 8 | M | 168 | 26 | Hypertension; asthma | 11 | 96 | 5 | 7 | 12 | Pneumonia |
| 9 | M | 170 | 19 | Hypertension | 23 | 64 | 12 | 2 | 16.5 | Pneumonia |
| 10 | M | 163 | 23 | Hypertension | 8 | 122 | 12 | 3 | 12.5 | Septic shock |
| Summary | 9M/1F | 169.5 ± 6.6 | 24 ± 4 | 14 ± 9 | 95.4 ± 27 | 9.3 ± 3.02 | 3.2 ± 1.8 | 15.45 ± 2.5 |
M, male; F, female; BMI, Body Mass Index; APACHE-II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive care unit; PaO2/FiO2, arterial partial pressure of O2/inspired fraction of O2 ratio; PEEP, positive end-expiratory pressure; MV, mechanical ventilation; ARDS, acute respiratory distress syndrome
Effects of prone position ventilation on respiratory, gas exchange, and hemodynamics
| T0 | T1 | T2 | Trend | Mauchly’s test of sphericity | |
|---|---|---|---|---|---|
| MV (l/min) | 7.47 ± 1.09 | 7.29 ± 0.92 | 7.62 ± 1.32 | 0.536 | < 0.001 |
| Crs (ml/cmH2O) | 27.70 ± 11.65 | 30.03 ± 11.36 | 33.52 ± 12.87a | < 0.01 | 0.061 |
| Set FiO2 | 0.70 [0.60–0.89] | 0.60 [0.59–0.69] | 0.60 [0.40–0.65] | < 0.05 | 0.441 |
| PaO2 (mmHg) | 66.98 ± 12.15 | 100.44 ± 20.54a | 125.35 ± 34.85a | < 0.0001 | 0.119 |
| PaO2/FiO2 (mmHg) | 95.40 ± 27.45 | 161.90 ± 44.68a | 221.40 ± 54.64a, b | < 0.0001 | 0.957 |
| PaCO2 (mmHg) | 50.55 [41.50–63.35] | 56.45 [46.33–69.93] | 49.90 [42.88–68.58] | 0.257 | 0.046 |
| ETCO2 (mmHg) | 36.00 [34.00–48.75] | 41.00 [35.00–50.00] | 37.50 [33.00–43.25] | 0.348 | 0.010 |
| Dead space-ABG | 26.84 [17.66–34.42] | 24.56 [21.64–33.43] | 20.02 [17.61–37.17] | 0.740 | 0.003 |
| HR (bpm) | 113.30 ± 19.81 | 108.00 ± 20.56 | 106.90 ± 24.53 | 0.387 | 0.198 |
| SBP (mmHg) | 116.20 ± 17.50 | 120.50 ± 17.80 | 121.60 ± 19.00 | 0.763 | 0.070 |
| MAP (mmHg) | 76.93 ± 15.97 | 84.83 ± 13.77 | 84.60 ± 17.33 | 0.360 | 0.092 |
| CVP (mmHg) | 10.00 [8.00–14.50] | 14.00 [10.50–15.00] | 13.00 [11.00–15.00] | 0.123 | 0.253 |
| Norepinephrine (µg/kg/min) | 0.17 [0–0.175] | 0.08 [0–0.175] | 0.02 [0–0.088]a | < 0.05 | 0.377 |
MV, minute ventilation; PaO2/FiO2, arterial partial pressure of O2/inspired fraction of O2 ratio; PaCO2, arterial partial pressure of CO2; ETCO2, end-tidal expired carbon dioxide pressure; ABG, arterial blood gas; HR, heart rate; SBP, systolic arterial blood pressure; MAP, mean arterial pressure; CVP, central venous pressure. Respiratory system static compliance (Crs) = Vt/(Pplat − PEEPtot) from the analysis of ventilation tracings during occlusions; Vt, tidal volume; Pplat, plateau pressure; PEEPtot, total positive end-expiratory pressure. T0: in the supine position; T1: 3 h after PP initiation; T2: at the end of PP
p value by one-way analysis of variance (ANOVA) for repeated measures
avs. T0, p < 0.05
bvs. T1, p < 0.05
Physiologic variables at the three different time points selected for the analysis of electrical impedance tomography data
| Variables | T0 | T1 | T2 | Trend | Mauchly’s test of sphericity |
|---|---|---|---|---|---|
| Tidal image region-global (%) | 82.90 ± 5.40 | 84.60 ± 7.31 | 92.50 ± 6.52a, b | < 0.0005 | 0.709 |
| Ventral of tidal image region (%) | 50.20 ± 10.44 | 46.60 ± 8.61 | 43.50 ± 7.03 | 0.140 | 0.030 |
| Dorsal of tidal image region (%) | 32.70 ± 12.14 | 38.00 ± 9.24a | 49.00 ± 7.32a, b | < 0.005 | 0.001 |
| ROI 1 of ventilation distribution (%) | 20.8 ± 9.7 | 15.8 ± 7.0 | 11.2 ± 4.5 | < 0.05 | 0.099 |
| ROI 2 of ventilation distribution (%) | 39.00 [36.50–43.00] | 37.00 [35.25–41.25] | 37.00 [31.00–42.00] | 0.315 | 0.030 |
| ROI 3 of ventilation distribution (%) | 31.50 ± 11.20 | 36.30 ± 7.85 | 37.90 ± 8.06 | 0.243 | 0.013 |
| ROI 4 of ventilation distribution (%) | 7.50 ± 3.24 | 8.50 ± 3.10 | 15.00 ± 3.74a, b | < 0.001 | 0.833 |
| GI index-ventilation (%) | 0.53 ± 0.06 | 0.52 ± 0.07 | 0.47 ± 0.05a | < 0.01 | 0.266 |
| Blood flow region-global (%) | 73.9 ± 9.9 | 74.4 ± 12.2 | 75.3 ± 7.2 | 0.817 | 0.022 |
| Ventral of blood flow region (%) | 37.70 ± 10.02 | 36.30 ± 8.52 | 29.30 ± 10.59 | < 0.05 | 0.102 |
| Dorsal of blood flow region (%) | 36.42 ± 6.20 | 38.20 ± 7.98 | 46.00 ± 9.29a | < 0.01 | 0.623 |
| ROI 1 of perfusion distribution (%) | 12.10 ± 4.66 | 10.40 ± 9.28 | 9.60 ± 10.89 | 0.742 | 0.554 |
| ROI 2 of perfusion distribution (%) | 38.20 ± 9.35 | 37.90 ± 5.59 | 28.80 ± 4.96a, b | < 0.01 | 0.268 |
| ROI 3 of perfusion distribution (%) | 40.20 ± 7.00 | 38.70 ± 7.13 | 42.30 ± 7.15 | 0.076 | 0.280 |
| ROI 4 of perfusion distribution (%) | 9.50 ± 6.49 | 13.00 ± 8.65 | 19.30 ± 8.03 | < 0.05 | 0.148 |
| GI index-perfusion (%) | 0.60 ± 0.12 | 0.59 ± 0.08 | 0.59 ± 0.10 | 0.993 | 0.088 |
| Matched region (%) | 52.50 ± 6.65 | 61.10 ± 7.39a | 67.40 ± 7.09a, b | < 0.0005 | 0.468 |
| Dead space-EIT (%) | 18.00 ± 4.69 | 18.10 ± 5.02 | 14.30 ± 5.89 | 0.099 | 0.154 |
| Shunt-EIT (%) | 29.50 ± 7.56 | 20.80 ± 6.71a | 18.30 ± 6.06a | < 0.005 | 0.023 |
ROI, Region of Interest; GI, Global Inhomogeneity. T0: in the supine position; T1: 3 h after PP initiation; T2: at the end of PP
p value by one-way analysis of variance (ANOVA) for repeated measures
avs. T0, p < 0.05
bvs. T1, p < 0.05
Fig. 2Evolution of Tidal image region (%) (A), Blood flow region (%) (C), ventilation (B) or perfusion distribution (%) (D) in the horizontal regions of interest (ROIs) at T0, T1, and T2. *vs. T0, p < 0.05. #vs. T1, p < 0.05
Fig. 3Comparisons of Matched Region (%) (A), Shunt-EIT (%) (B), and Dead Space-EIT (%) (C) at T0, T1, and T2. *p < 0.05. PaO2/FiO2 was significantly correlated with Matched Region (%) (D) and Shunt-EIT (%) (E), but not with Dead Space-EIT(%) (F)